(Q54599747)

English

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

0 references

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Yoon-Seon Lee

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Dong Jin Suh

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Young-Suk Lim

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Suk Won Jung

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Kang Mo Kim

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Han Chu Lee

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Young-Hwa Chung

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Yung Sang Lee

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Wangdon Yoo

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Soo-Ok Kim

10

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

language of work or name

0 references

publication date

1 June 2006

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

43

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

1385-1391

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

Diagnosis of small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

21 January 2018

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus resistance to antivirals: clinical implications and management.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B: update of recommendations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Tbe complete nudeotide sequences of the cloned hepatitis B vims DNA; subtype adr and adw

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Virologic response and resistance to adefovir in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis B: current challenges and future directions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Population genotyping of hepatitis C virus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of short DNA fragments.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21189

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.21189

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16729316

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54599747&oldid=1590417802"